US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about CYB004

Recent news which mentions CYB004

Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
Tickers CYBN NEWS
Tags Trading Ideas Psychedelics FDA
From Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
Tickers CYBN DMT
Tags Cybin DMT Benzinga
From Benzinga